RISK OF PARKINSON'S DISEASE (PD) IN PATIENTS TAKING ADRENERGIC DRUG TREATMENTS

被引：1
|
作者：
Stacey, J. [1 ]
Lovestone, S. [2 ]
Harrison, P. [2 ]
Denis, M. [2 ]
Nevado-Holgado, A. [2 ]
Newby, D. [2 ]
机构：
[1] TriNetX Inc, Cambridge, MA USA
[2] Univ Oxford, Oxford, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1969
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND2
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [31] OCT2 and Parkinson's disease (PD) risk
    Tanner, C. M.
    Giacomini, K.
    Nelson, L. M.
    Kamel, F.
    Bhudhikanok, G. S.
    Van Den Eeden, S. K.
    Umbach, D. M.
    Korell, M.
    Topol, B.
    Goldman, S. M.
    Hoppin, J. A.
    Taylor, T.
    Floren, L. C.
    Lee, S. W.
    Blair, A.
    Ross, G. W.
    Langston, J. W.
    MOVEMENT DISORDERS, 2008, 23 (01) : S244 - S244
  • [32] Fatigue in Parkinson's disease (PD): Prevalence and Risk Factors
    Falup-Pecurariu, C.
    Murasan, I.
    Rusu, D.
    Opritoiu, B.
    Ungureanu, L.
    Irincu, L.
    Despa, I.
    Diaconu, S.
    MOVEMENT DISORDERS, 2024, 39 : S159 - S159
  • [33] Seborrheic Dermatitis and Risk of Future Parkinson's Disease (PD)
    Tanner, Caroline
    Albers, Kathleen
    Goldman, Samuel
    Fross, Robin
    Leimpeter, Amethyst
    Klingman, Jeffrey
    Van den Eeden, Stephen
    NEUROLOGY, 2012, 78
  • [34] What are the factors affecting drug therapy in Parkinson's disease (PD)?
    Nasar, M. A.
    Hasoon, M.
    Turton, J.
    Ngwira, J.
    MOVEMENT DISORDERS, 2011, 26 : S295 - S296
  • [35] Risk Factors Of Parkinson's disease (PD) A Case-Control Study In Tunisian Patients
    Sellami, S.
    Farhat, N.
    Moalla, K. S.
    Bouattour, N.
    Daoued, S.
    Sakka, S.
    Damak, M.
    Mhiri, C.
    MOVEMENT DISORDERS, 2024, 39 : S78 - S78
  • [36] Increased risk of developing depression for patients with Parkinson's disease (PD): A retrospective cohort study
    Hsu, Y. -T.
    Yang, Y. -W.
    Liao, C. -C.
    Hsu, C. -Y.
    Tsui, C. -H.
    Sung, F. -C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S282 - S282
  • [37] Is drug profile a risk factor to hallucinations emergence in patients with advanced Parkinson's disease?
    Merims, D
    Shabtai, H
    Weizman, N
    Peretz, C
    Korczyn, A
    Giladi, N
    MOVEMENT DISORDERS, 2004, 19 : S148 - S148
  • [38] Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments
    Chao Gao
    Jun Liu
    Yuyan Tan
    Shengdi Chen
    Translational Neurodegeneration, 9
  • [39] Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments
    Gao, Chao
    Liu, Jun
    Tan, Yuyan
    Chen, Shengdi
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [40] Osteoporosis risk in patients with Parkinson's disease
    Hussain, M.
    Pollock, L.
    Solanki, T.
    Cooper, S. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 108 - 108
12345